Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2020
Mar. 31, 2020
Current assets    
Cash $ 15,721,616 $ 9,604,780
Accounts receivable 206,729 206,729
Prepaid expenses and other current assets 166,944 229,604
Total current assets 16,095,289 10,041,113
Property and equipment, net 149,661 140,484
Right-of-use lease asset 112,779 136,426
Patents, net 57,366 57,504
Deposits 12,159 12,159
Total assets 16,427,254 10,387,686
Current liabilities    
Accounts payable 251,194 285,036
Due to related parties 131,844 111,707
Deferred revenue 306,729 100,000
Lease liability, current portion 100,430 98,557
Other current liabilities 433,120 472,420
Total current liabilities 1,223,317 1,067,720
Lease liability, less current portion 16,832 42,540
Total liabilities 1,240,149 1,110,260
Stockholders' Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 12,070,393 and 9,367,171 shares issued and outstanding as of June 30, 2020 and March 31, 2020, respectively 12,072 9,368
Additional paid-in capital 128,744,684 121,426,563
Accumulated deficit (113,436,664) (112,026,381)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests 15,320,092 9,409,550
Noncontrolling interests (132,987) (132,124)
Total stockholders' equity 15,187,105 9,277,426
Total liabilities and stockholders' equity $ 16,427,254 $ 10,387,686